Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1.
Yun J, Espinoza I, Pannuti A, Romero D, Martinez L, Caskey M, Stanculescu A, Bocchetta M, Rizzo P, Band V, Band H, Kim HM, Park SK, Kang KW, Avantaggiati ML, Gomez CR, Golde T, Osborne B, Miele L. Yun J, et al. Among authors: caskey m. J Cell Physiol. 2015 Dec;230(12):3115-27. doi: 10.1002/jcp.25052. J Cell Physiol. 2015. PMID: 26033683 Free PMC article.
Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells.
Yun J, Pannuti A, Espinoza I, Zhu H, Hicks C, Zhu X, Caskey M, Rizzo P, D'Souza G, Backus K, Denning MF, Coon J, Sun M, Bresnick EH, Osipo C, Wu J, Strack PR, Tonetti DA, Miele L. Yun J, et al. Among authors: caskey m. Oncogenesis. 2013 Aug 5;2(8):e60. doi: 10.1038/oncsis.2013.26. Oncogenesis. 2013. PMID: 23917222 Free PMC article.
Multi-Omic Atlas reveals cytotoxic phenotype and ROS-linked metabolic quiescence as key features of CTL-resistant HIV-infected CD4 + T-cells.
Herrera A, Leyre L, Weiler J, Linden NL, Huynh TT, Wang F, Kovacs C, Caskey M, Zumbo P, Amiama MA, Terry S, Ho YC, Betel D, Jones RB. Herrera A, et al. Among authors: caskey m. bioRxiv [Preprint]. 2024 Dec 23:2024.12.22.629960. doi: 10.1101/2024.12.22.629960. bioRxiv. 2024. PMID: 39763858 Free PMC article. Preprint.
Potential for broadly neutralising antibodies as PrEP.
Fidler S, Caskey M. Fidler S, et al. Among authors: caskey m. Lancet HIV. 2025 Jan;12(1):e2-e3. doi: 10.1016/S2352-3018(24)00308-4. Epub 2024 Dec 10. Lancet HIV. 2025. PMID: 39667378 No abstract available.
Surgical Necrotizing Enterocolitis and Spontaneous Intestinal Perforation Lead to Severe Growth Failure in Infants.
Speer AL, Lally KP, Pedroza C, Zhang Y, Poindexter BB, Chwals WJ, Hintz SR, Besner GE, Stevenson DK, Ohls RK, Truog WE, Stoll BJ, Rysavy MA, Das A, Tyson JE, Blakely ML; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Speer AL, et al. Ann Surg. 2024 Sep 1;280(3):432-443. doi: 10.1097/SLA.0000000000006378. Epub 2024 Jun 7. Ann Surg. 2024. PMID: 39264354
The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysis.
Lee MJ, Eason M, Castagna A, Laura G, De Scheerder MA, Riley J, Tebas P, Gunst J, Søgaard O, Florence E, Kroon E, De Souza M, Mothe B, Caskey M, Fidler S. Lee MJ, et al. Among authors: caskey m. J Int AIDS Soc. 2024 Aug;27(8):e26349. doi: 10.1002/jia2.26349. J Int AIDS Soc. 2024. PMID: 39155436 Free PMC article.
Transcription of HIV-1 at sites of intact latent provirus integration.
Teixeira AR, Bittar C, Silva Santos GS, Oliveira TY, Huang AS, Linden N, Ferreira IATM, Murdza T, Muecksch F, Jones RB, Caskey M, Jankovic M, Nussenzweig MC. Teixeira AR, et al. Among authors: caskey m. J Exp Med. 2024 Sep 2;221(9):e20240391. doi: 10.1084/jem.20240391. Epub 2024 Aug 14. J Exp Med. 2024. PMID: 39141127 Free PMC article.
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIV.
Mayer BT, Zhang L, deCamp AC, Yu C, Sato A, Angier H, Seaton KE, Yates N, Ledgerwood JE, Mayer K, Caskey M, Nussenzweig M, Stephenson K, Julg B, Barouch DH, Sobieszczyk ME, Edupuganti S, Kelley CF, McElrath MJ, Gelderblom HC, Pensiero M, McDermott A, Gama L, Koup RA, Gilbert PB, Cohen MS, Corey L, Hyrien O, Tomaras GD, Huang Y. Mayer BT, et al. Among authors: caskey m. Pharmaceutics. 2024 Apr 27;16(5):594. doi: 10.3390/pharmaceutics16050594. Pharmaceutics. 2024. PMID: 38794258 Free PMC article.
Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 Trial.
Corado KC, Chew KW, Giganti MJ, Mu Y, Fletcher CV, Currier JS, Daar ES, Wohl DA, Li JZ, Moser CB, Ritz J, Javan AC, Neytman G, Caskey M, Hughes MD, Smith DM, Eron JJ; ACTIV-2/A5401 Study Team. Corado KC, et al. Among authors: caskey m. Pathog Immun. 2024 May 6;9(1):138-155. doi: 10.20411/pai.v9i1.660. eCollection 2024. Pathog Immun. 2024. PMID: 38746756 Free PMC article.
191 results